Long and short-term outcomes of Gestational Diabetes Mellitus (GDM) among South Asian women – A community-based study

Sudasinghe, B.H.; Wijeyaratne, Chandrika; Ginige, P.

doi:10.1016/j.diabres.2018.04.013

Cited by 34 publications

(31 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our initial search yielded 7970 publications, of which 109 articles were reviewed in full and 43 studies were included in the final analysis [3,11,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55]. Forty studies reported on T2DM [3,11,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43…”

Section: Resultsmentioning

confidence: 99%

The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis

Benhalima

Lens

Bosteels

et al. 2019

JCM

View full text Add to dashboard Cite

The aim of the study was to assess the postpartum risk for glucose intolerance since the introduction of the ‘International Association of Diabetes and Pregnancy Study Groups’ (IADPSG) criteria for gestational diabetes mellitus (GDM). Studies published since 2010 were included, which evaluated the risk for type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), and cardiovascular (CV) events in women with previous GDM compared to normal glucose tolerant women. We included forty-three studies, evaluating 4,923,571 pregnant women of which 5.8% (284,312) had a history of GDM. Five studies used IADPSG criteria (n = 6174 women, 1314 with GDM). The overall pooled relative risk (RR) for postpartum T2DM was 7.42 (95% CI: 5.99–9.19) and the RR for postpartum T2DM with IADPSG criteria was 6.45 (95% CI: 4.74–8.77) compared to the RR of 9.08 (95% CI: 6.96–11.85; p = 0.17) for postpartum T2DM based on other diagnostic criteria. The RR for postpartum IGT was 2.45 (95% CI: 1.92–3.13), independent of the criteria used. None of the available studies with IADPSG criteria evaluated the risk for CV events. Women with a history of GDM based on the IADPSG criteria have a similarly increased risk for postpartum glucose intolerance compared to GDM based on other diagnostic criteria. More studies with GDM based on the IADPSG criteria are needed to increase the quality of evidence concerning the long-term metabolic risk.

show abstract

Section: Resultsmentioning

confidence: 99%

The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis

Benhalima

Lens

Bosteels

et al. 2019

JCM

View full text Add to dashboard Cite

show abstract

“…The most important complications of gestational diabetes are prematurity and abnormal birth weight. Many studies in the literature have found that gestational diabetes was a risk factor for premature labor, and macrosomia (> 4000 g) rates were high despite premature labor [18][19][20]. There is no study in the literature about neonatal hearing evaluation of diabetic pregnant women who had delivered without any complication.…”

Section: Discussionmentioning

confidence: 99%

Gestasyonel diyabet yenidoğan işitme kaybında bir risk faktörü müdür?

Hanege

Çelik

et al. 2019

Archives of Clinical and Experimental Medicine

View full text Add to dashboard Cite

Aim: Newborn hearing screening is important for early detection of hearing loss in newborns. Gestational diabetes is a metabolic disease that can occur in pregnancy and cause complications such as those in the other diabetes mellitus patients. As uncomplicated gestational diabetes has not been described as a cause for prenatal complications in the literature, this study aimed to determine whether gestational diabetes is a risk factor for hearing impairment among newborns. Methods: This retrospective study included infants born between 2015 and 2017. The infants were divided into two groups: Control group consisted of 100 randomly selected children of healthy mothers. Study group consisted of 79 infants whose mothers had gestational diabetes mellitus. Exclusion criteria included other risk factors and 8 infants were excluded from the study due to risk factors other than gestational diabetes mellitus. The results of transient evoked otoacoustic emissions in infants of mothers with gestational diabetes were compared with those of infants of healthy mothers. Results: In this study, we compared transient evoked otoacoustic emission results of 71 infants of gestational diabetic mothers with 100 infants of healthy mothers. All the infants of healthy mothers, as well as the infants of mothers with gestational diabetes without risk factors, passed the transient evoked otoacoustic emission test. Conclusions: There was no difference detected in the hearing screening results between infants of mothers with gestational diabetes and infants of healthy mothers.

show abstract

“…When the possible alterations in glucose levels according to the sample tubes and assay duration reported in the previous studies are considered, it is clearly possible that there would be cases underdiagnosed for GDM. Unidentified cases with the 50 g OGCT may result in increased rates of adverse maternal outcomes, obstetric complications, foetal macrosomia or polyhydramnios which may not be interpreted as a consequence of GDM by obstetricians, in the absence of abnormal glucose test results 10‐14 …”

Section: Introductionmentioning

confidence: 99%

“…Unidentified cases with the 50 g OGCT may result in increased rates of adverse maternal outcomes, obstetric complications, foetal macrosomia or polyhydramnios which may not be interpreted as a consequence of GDM by obstetricians, in the absence of abnormal glucose test results. [10][11][12][13][14] Analysis of blood samples for the screening of gestational diabetes is a recent topic of concern. Up-to-date, this subject has not been evaluated in detail yet, and the reported data on pre-analytical process are limited.…”

mentioning

confidence: 99%

Different pre‐analytical techniques and the results of 50 g oral glucose challenge tests

Eldem¹,

Oskovi-Kaplan

Engin-Üstün

et al. 2021

Eur J Clin Investigation

View full text Add to dashboard Cite

Accurate measurement of plasma glucose has consequential results for the diagnosis of diabetes mellitus regarding the different cut-off levels of several diagnostic criteria. Ex vivo glycolysis continues in blood sample tubes until analysis, and this process is affected from the duration until analysis, immediate centrifugation and the room temperature. 1,2 These factors cause a time-dependent decrease in the plasma glucose levels until analysis.The efficacy of additives to inhibit glycolysis in blood tubes has been previously investigated but a limited effect on stabilization of blood glucose was reported. 1,3 Sodium fluoride (NaF) in combination with potassium oxalate (KOx) as an additive

show abstract

Long and short-term outcomes of Gestational Diabetes Mellitus (GDM) among South Asian women – A community-based study

Cited by 34 publications

References 19 publications

The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis

The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis

Gestasyonel diyabet yenidoğan işitme kaybında bir risk faktörü müdür?

Different pre‐analytical techniques and the results of 50 g oral glucose challenge tests

Contact Info

Product

Resources

About